The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815 · cited 1×
“(oxaliplatin 85 mg/m(2), LV 200 mg/m(2), 5-FU bolus 400 mg/m(2) followed by 600 mg/m(2) 22-h infusion, every 14 days [19], or oxaliplatin 85 mg/m(2), Lfolinic acid 175 mg, 5-FU bolus 400 mg/m(2) followed by 2400 mg/m(2) 46-h infusion every 14 days or oxaliplatin 85 mg/m(2) every 14 days and weekly LV 200 mg/m(2) and 5…”
MethodSaltz, L. B., Clarke, S., Díaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Lichinitser, M., Yang, T.-S., Rivera, F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9930 · Cited by 2,955
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G. J., Schlag, P. M., Rougier, P., Bechstein, W. O., Primrose, J. N., Walpole, E. T., Finch-Jones, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60455-9 · Cited by 1,937
Self-citationAbdalla, E. K., Vauthey, J.-N., Ellis, L. M., Ellis, V., Pollock, R., Broglio, K. R., Hess, K., & Curley, S. A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128305.90650.71 · Cited by 1,750
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Tol, J., Koopman, M., Cats, A., Rodenburg, C. J., Creemers, G. J. M., Schrama, J. G., Erdkamp, F. L. G., Vos, A. H., van Groeningen, C. J., Sinnige, H. A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808268 · Cited by 1,341
Self-citationKopetz, S., Chang, G. J., Overman, M. J., Eng, C., Sargent, D. J., Larson, D. W., Grothey, A., Vauthey, J.-N., Nagorney, D. M., & McWilliams, R. R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5278 · Cited by 1,339
Mulier, S., Ni, Y., Jamart, J., Ruers, T., Marchal, G., & Michel, L. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000171032.99149.fe · Cited by 688
Self-citationMitry, E., Fields, A. L. A., Bleiberg, H., Labianca, R., Portier, G., Tu, D., Nitti, D., Torri, V., Elias, D., O'Callaghan, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3781 · Cited by 583 · cited 2×
“5 (0–12), in the systemic treatment group, it was 10 [1–12] (Table 2).”
BackgroundAlberts, S. R., Horvath, W. L., Sternfeld, W. C., Goldberg, R. M., Mahoney, M. R., Dakhil, S. R., Levitt, R., Rowland, K., Nair, S., Sargent, D. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.740 · Cited by 537
House, M. G., Ito, H., Gönen, M., Fong, Y., Allen, P. J., DeMatteo, R. P., Brennan, M. F., Blumgart, L. H., Jarnagin, W. R., & D'Angelica, M. I. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.12.040 · Cited by 517
Wong, S. L., Mangu, P. B., Choti, M. A., Crocenzi, T. S., Dodd, G. D., Dorfman, G. S., Eng, C., Fong, Y., Giusti, A. F., Lu, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4450 · Cited by 433
Self-citationRadiofrequency Ablation of 100 Hepatic Metastases with a Mean Follow-Up of More Than 1 Year
de Baere, T., Elias, D., Dromain, C., Din, M. G. E., Kuoch, V., Ducreux, M., Boige, V., Lassau, N., Marteau, V., Lasser, P., et al. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.175.6.1751619 · Cited by 393
Sanoff, H. K., Sargent, D. J., Campbell, M. E., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C., & Goldberg, R. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7147 · Cited by 305
Vogl, T. J., Straub, R., Eichler, K., Söllner, O., & Mack, M. G. (2004) · Radiology · doi:10.1148/radiol.2302020646 · Cited by 286
Gillams, A. R., & Lees, W. R. (2009) · European Radiology · doi:10.1007/s00330-008-1258-5 · Cited by 254
Survival After Radiofrequency Ablation of Colorectal Liver Metastases: 10-Year Experience
Siperstein, A. E., Berber, E., Ballem, N., & Parikh, R. T. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318155a7b6 · Cited by 240
Ychou, M., Viret, F., Kramar, A., Desseigne, F., Mitry, E., Guimbaud, R., Delpero, J. R., Rivoire, M., Quénet, F., Portier, G., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0588-3 · Cited by 164
Self-citationBarone, C. A., Nuzzo, G., Cassano, A., Basso, M., Schinzari, G., Giuliante, F., D’Argento, E., Trigila, N., Astone, A., & Pozzo, C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603988 · Cited by 127
Cited by
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Self-citationPalma, D. A., Olson, R., Harrow, S., Gaede, S., Louie, A. V., Haasbeek, C., Mulroy, L., Lock, M., Rodrigues, G. B., Yaremko, B. P., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32487-5 · Cited by 1,857
Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Self-citationImage-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update
Ahmed, M., Solbiati, L., Brace, C. L., Breen, D. J., Callstrom, M. R., Charboneau, J. W., Chen, M.-H., Choi, B. I., de Baère, T., Dodd, G. D., et al. (2014) · Radiology · doi:10.1148/radiol.14132958 · Cited by 1,346
Palma, D. A., Olson, R., Harrow, S., Gaede, S., Louie, A. V., Haasbeek, C., Mulroy, L., Lock, M., Rodrigues, G. B., Yaremko, B. P., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00818 · Cited by 1,300
Metadata
- Authors
- Ruers, T., Punt, C., Van Coevorden, F., Pierie, J. P. E. N., Borel-Rinkes, I., Ledermann, J. A., Poston, G., Bechstein, W., Lentz, M. A., Mauer, M., Van Cutsem, E., Lutz, M. P., & Nordlinger, B.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 23
- Issue
- 10
- Pages
- 2619-2626
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2170281599
- Cited by
- 442
- References
- 22
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.